Trials / Completed
CompletedNCT01376271
Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is designed to evaluate the safety and efficacy of paroxetine on the long-term use in Japanese Social Anxiety Disorder (SAD) subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2011-06-20
- Last updated
- 2014-07-02
Source: ClinicalTrials.gov record NCT01376271. Inclusion in this directory is not an endorsement.